At the outset the Commission observes that the eligible beneficiaries are pharmaceutical undertakings that are clearly engaged in an economic activity. As such, the beneficiaries are to be regarded as undertakings in the meaning of Article 107(1) TFEU.
69 6. ASSESSMENT › 6.1. Existence of aid › Selective advantage to an undertaking, Decision_act (EU) 2015/1300
In forcesince 27 Mar 2015